Interesting facts
Interesting Facts about 8-[4-(4-fluorophenyl)-4-oxo-butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
This fascinating compound, known for its complex structure, offers a multitude of interesting features that chemists find captivating. Let’s break down some of these intriguing aspects:
- Unique Structure: The compound contains a spiro arrangement, which is characterized by two or more rings that share only one common atom. This arrangement often leads to unique properties that differentiate it from typical linear compounds.
- Fluorine Substitution: The presence of a fluorophenyl group enhances the compound's chemical stability and can affect its reactivity, making it interesting for researchers in medicinal chemistry.
- Potential Application: Compounds like this one with triaza groups have been studied for their potential biological activities, including anti-cancer and anti-inflammatory properties, fueling interest in drug development.
- Versatile Chemistry: This molecule can serve as a platform for further modifications, allowing chemists to tailor its properties for various applications, including pharmaceuticals and agrochemicals.
- Research Significance: The synthesis and study of such compounds can lead to advancements in understanding the interactions between structure and function. As noted by researchers, "The exploration of spiro compounds paves the way for novel therapeutic agents."
Overall, 8-[4-(4-fluorophenyl)-4-oxo-butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one illustrates the intricate relationship between chemical structure and biological activity, making it a fascinating subject for ongoing study in the fields of organic and medicinal chemistry.
Synonyms
spiperone
749-02-0
Spiropitan
Spiroperidol
Espiperona
Spiperonum
R 5147
[3H]spiperone
Spiperonum [INN-Latin]
[3H]-spiperone
Espiperona [INN-Spanish]
E 525
NSC 170983
Spiperone [USAN:INN:BAN:JAN]
8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
Spiropitan (TN)
EINECS 212-024-0
8-(3-(p-Fluorobenzoyl)propyl)-1-phenyl-1,3,8-triazaspiro(4.5)decan-4-one
8-(3-p-Fluorobenzoyl-1-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro(4,5)decane
NSC-170983
BRN 0632204
4X6E73CJ0Q
CHEBI:9233
MLS000028615
DTXSID5045205
Spiroperidol;R-5147
SPIPERONE [INN]
SPIPERONE [JAN]
1,3,8-Triazaspiro(4.5)decan-4-one, 8-(4-(4-fluorophenyl)-4-oxobutyl)-1-phenyl-
SPIPERONE [MI]
SPIPERONE [USAN]
R-5147
SPIPERONE [MART.]
SPIPERONE [WHO-DD]
SMR000058674
Butyrophenone, 4'-fluoro-4-(4-oxo-1-phenyl-1,3,8-triazaspiro(4,5)decan-8-yl)-
CHEMBL267930
DTXCID3025205
1,3,8-Triazaspiro(4.5)decan-4-one, 8-(3-(p-fluorobenzoyl)propyl)-1-phenyl-
NSC170983
NCGC00015964-09
Spiroperone
CAS-749-02-0
Spiperonum (INN-Latin)
Espiperona (INN-Spanish)
SPIPERONE (MART.)
8-[3-(p-Fluorobenzoyl)propyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
1,3,8-Triazaspiro[4.5]decan-4-one, 8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-
8-(4-(4-Fluorophenyl)-4-oxobutyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
8-[4-(4-fluorophenyl)-4-oxidanylidene-butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
Spiroperidone
1,3,8-Triazaspiro[4.5]decan-4-one, 8-[3-(p-fluorobenzoyl)propyl]-1-phenyl-
UNII-4X6E73CJ0Q
SR-01000000261
Spiperone, solid
8-(4-(4-fluorophenyl)-4-oxobutyl)-1-phenyl-1,3,8-triazaspiro(4.5)decan-4-one
Prestwick_624
[3H]-Spiroperidol
Spectrum_001143
Tocris-0995
Spiperone (JAN/USAN)
regid855701
Opera_ID_1551
Prestwick0_000288
Prestwick1_000288
Prestwick2_000288
Prestwick3_000288
Spectrum2_001426
Spectrum3_001460
Spectrum4_000451
Spectrum5_000987
Lopac-S-7395
GTPL99
4-Phenyl-8-[3-(4-fluorobenzoyl)propyl]-1-oxo-2,4,8-triazaspiro[4,5]decane
cid_5265
Lopac0_001069
REGID_for_CID_5265
BSPBio_000196
BSPBio_002959
KBioGR_000862
KBioSS_001623
MLS001076321
DivK1c_000566
SCHEMBL116031
SPECTRUM1501152
SPBio_001532
SPBio_002415
BPBio1_000216
GTPL3300
BDBM21397
HMS501M08
KBio1_000566
KBio2_001623
KBio2_004191
KBio2_006759
KBio3_002459
TQP0726
NINDS_000566
HMS1568J18
HMS1921L09
HMS2089E16
HMS2092H17
HMS2095J18
HMS2235E11
HMS3371L01
HMS3712J18
Pharmakon1600-01501152
HY-B1371
Tox21_110269
CCG-38975
MFCD00055099
NSC757864
AKOS024282958
Tox21_110269_1
NSC-757864
SDCCGSBI-0051039.P004
8-[4-(4-fluorophenyl)-4-oxo-butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
IDI1_000566
NCGC00015964-01
NCGC00015964-02
NCGC00015964-03
NCGC00015964-04
NCGC00015964-05
NCGC00015964-06
NCGC00015964-07
NCGC00015964-08
NCGC00015964-10
NCGC00015964-11
NCGC00015964-12
NCGC00015964-13
NCGC00015964-17
NCGC00015964-25
NCGC00016536-01
NCGC00022260-02
NCGC00022260-04
NCGC00022260-05
NCGC00022260-06
NCGC00022260-07
DA-77979
MS-26659
SBI-0051039.P003
AB00052224
CS-0013110
NS00042134
D01051
AB00052224-15
AB00052224_16
L000569
Q3077150
SR-01000000261-5
SR-01000000261-8
BRD-K55468218-001-05-5
BRD-K55468218-001-26-1
BRD-K55468218-003-01-0
BRD-K55468218-003-02-8
WLN: T6N DXTJ A3VR DF& D-& CT5MVXN EHJ DR
8-[3-(p-Fluorobenzoyl)propyl]-1-phenyl-1,8-triazaspiro[4.5]decan-4-one
1,8-Triazaspiro[4.5]decan-4-one, 8-[3-(p-fluorobenzoyl)propyl]-1-phenyl-
1,8-Triazaspiro[4.5]decan-4-one, 8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-
8-[4-(4-fluorophenyl)-4-keto-butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
8-[4-(4-fluorophenyl)-4-oxo-butyl]-4-phenyl-2,4,8-triazaspiro[4.5]decan-1-one
1-(4-Fluorophenyl)-4-(4-hydroxy-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-en-8-yl)-1-butanone #
212-024-0
SIP
Solubility of 8-[4-(4-fluorophenyl)-4-oxo-butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
The solubility of the compound 8-[4-(4-fluorophenyl)-4-oxo-butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (C26H26F2N2O) can provide valuable insights for various applications. However, its solubility characteristics can be somewhat complex due to its unique structure.
Factors Influencing Solubility:
Typically, compounds resembling this structure may exhibit varied solubility patterns:
In conclusion, to assess the precise solubility of this compound, empirical testing in various solvents would be essential. As always, understanding the solubility is crucial for formulation development and application in pharmaceutical contexts!